Jacobs Levy Equity Management’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-127,890
Closed -$3.36M 1137
2022
Q1
$3.36M Sell
127,890
-62,725
-33% -$1.53M 0.02% 500
2021
Q4
$4.52M Sell
190,615
-11,932
-6% -$294K 0.03% 448
2021
Q3
$5.08M Buy
202,547
+36,622
+22% +$933K 0.03% 429
2021
Q2
$4.31M Sell
165,925
-100,827
-38% -$2.74M 0.03% 463
2021
Q1
$6.83M Buy
266,752
+63,504
+31% +$1.63M 0.05% 363
2020
Q4
$4.07M Buy
203,248
+4,042
+2% +$79.2K 0.04% 434
2020
Q3
$3.41M Buy
199,206
+26,639
+15% +$504K 0.04% 421
2020
Q2
$3.77M Buy
172,567
+127,607
+284% +$2.92M 0.04% 400
2020
Q1
$1.04M Buy
+44,960
New +$1.31M 0.01% 609
2017
Q2
Sell
-19,784
Closed -$777K 1038
2017
Q1
$777K Sell
19,784
-67,380
-77% -$2.53M 0.02% 595
2016
Q4
$3.03M Buy
+87,164
New +$3.42M 0.06% 340
2014
Q2
Sell
-89,950
Closed -$2.32M 962
2014
Q1
$2.32M Sell
89,950
-8,600
-9% -$217K 0.04% 377
2013
Q4
$2.22M Sell
98,550
-23,960
-20% -$463K 0.03% 413
2013
Q3
$1.74M Buy
122,510
+26,700
+28% +$357K 0.03% 433
2013
Q2
$1.31M Buy
+95,810
New +$1.31M 0.02% 511

Other funds holding NTUS

Jacobs Levy Equity Management's NTUS Position: Q2 2022 in Review

Jacobs Levy Equity Management sold out of Natus Medical Inc (NTUS) in Q2 2022, closing a stake of 127,890 shares — an estimated $3.36M sold.

Jacobs Levy Equity Management first reported a position in NTUS in Q2 2013 and held it in 15 quarters. The position peaked at $6.83M in Q1 2021. 186 funds tracked by Wall St. Rank hold NTUS as of Q2 2022.

  • Jacobs Levy Equity Management reported no remaining Natus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 127,890 Natus Medical Inc shares in Q2 2022, an estimated $3.36M.
  • Jacobs Levy Equity Management first reported a position in Natus Medical Inc in Q2 2013 and held it in 15 quarters.
  • Jacobs Levy Equity Management's Natus Medical Inc position peaked at $6.83M in Q1 2021.
  • 186 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2022, filed 15 Aug 2022.